Key points are not available for this paper at this time.
Deeg and Steuten address the financial, societal, and individual costs of aggressive treatment with curative intent in older patients with hematologic cancers and suggest that in some cases, palliative care might be a preferred alternative.
Deeg et al. (2015) studied this question.